JULIUS NWOSU: Open Payments
NPI 1508839267 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$38,844 in 299 payments from 21 companies in 2025. Trend: 2023 $62,939 · 2024 $48,700 · 2025 $38,844
Speaker / faculty: $25,191Travel & lodging: $7,366Food & beverage: $6,287
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 78 | $26,897 |
| ViiV Healthcare Company | 66 | $7,168 |
| ABBVIE INC. | 15 | $1,956 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $491 |
| AstraZeneca Pharmaceuticals LP | 14 | $420 |
| Ardelyx, Inc. | 19 | $366 |
| Novo Nordisk Inc | 7 | $282 |
| Astellas Pharma US Inc | 8 | $239 |
| SCILEX PHARMACEUTICALS INC. | 19 | $168 |
| Merck Sharp & Dohme LLC | 6 | $153 |
Products named: Biktarvy, Epclusa, DOVATO, QULIPTA, RELISTOR, APRETUDE, AIRSUPRA, IBSRELA.
Industry payments across NY — which companies pay providers there.
